Page last updated: 2024-08-26

fulvestrant and Carcinoma in Situ

fulvestrant has been researched along with Carcinoma in Situ in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexi, X; Bouwman, P; Dijcks, F; Jonkers, J; Klarenbeek, S; Liu, X; van de Ven, M; van der Burg, E; Zwart, W1
Bundred, NJ; Gandhi, A; Holland, PA; Knox, WF; Potten, CS1

Other Studies

2 other study(ies) available for fulvestrant and Carcinoma in Situ

ArticleYear
BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.
    The Journal of pathology, 2018, Volume: 246, Issue:1

    Topics: Animals; BRCA1 Protein; Carcinoma in Situ; Cell Proliferation; Cell Transformation, Neoplastic; Drug Implants; Estradiol; Estrenes; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogen Replacement Therapy; Female; Fulvestrant; Mammary Neoplasms, Experimental; Mice, 129 Strain; Mice, Transgenic; Ovariectomy; Progesterone; Receptors, Progesterone; Signal Transduction; Time Factors; Tumor Burden; Tumor Suppressor Proteins

2018
Effects of a pure antiestrogen on apoptosis and proliferation within human breast ductal carcinoma in situ.
    Cancer research, 2000, Aug-01, Volume: 60, Issue:15

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma in Situ; Cell Division; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Transplantation; Receptors, Estrogen; Transplantation, Heterologous

2000